Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnamurthy Sekar

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Pediatrics|March 3, 2020
Volume Targeted Ventilation and High Frequency Ventilation as the Primary Modes of Respiratory Support for ELBW Babies: What Does the Evidence Say?Abhrajit Ganguly, Abhishek Makkar, Krishnamurthy Sekar
Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses|January 11, 2021
The Effect of a Continuous Milk Warming System on Weight Gain in Very Low Birth-Weight Infants: A Randomized Controlled TrialSusan M Bedwell, Barbara Buster, Krishnamurthy Sekar
Frontiers in Pediatrics|April 19, 2021
The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?Frederico Vieira, Marjorie Makoni, Edgardo Szyld, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|November 3, 2012
A Cost Minimization Comparison of Two Surfactants-Beractant and Poractant alfa-Based Upon Prospectively Designed, Comparative Clinical Trial DataWallace Marsh, James Smeeding, John M York, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 26, 2019
Health Economics and Outcomes of Surfactant Treatments for Respiratory Distress Syndrome Among Preterm Infants in US Level III/IV Neonatal Intensive Care UnitsKrishnamurthy Sekar, Daniel Fuentes, Michelle R Krukas-Hampel, et al.
American Journal of Perinatology|April 16, 2004
A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infantsRangasamy Ramanathan, Maynard R Rasmussen, Dale R Gerstmann, et al.
Children (Basel, Switzerland)|June 2, 2021
Inhaled Nitric Oxide at Birth Reduces Pulmonary Vascular Resistance and Improves Oxygenation in Preterm LambsSatyan Lakshminrusimha, Sylvia F Gugino, Krishnamurthy Sekar, et al.
Pediatric Research|November 1, 2019
Inhaled nitric oxide as an adjunct to neonatal resuscitation in premature infants: a pilot, double blind, randomized controlled trialKrishnamurthy Sekar, Edgardo Szyld, Michael McCoy, et al.
The Journal of Pediatrics|June 20, 2020
Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical TrialRangasamy Ramanathan, Manoj Biniwale, Krishnamurthy Sekar, et al.
The Journal of Pediatrics|August 21, 2020
ReplyRangasamy Ramanathan, Manoj Biniwale, Krishnamurthy Sekar, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Pediatrics|March 3, 2020
Volume Targeted Ventilation and High Frequency Ventilation as the Primary Modes of Respiratory Support for ELBW Babies: What Does the Evidence Say?Abhrajit Ganguly, Abhishek Makkar, Krishnamurthy Sekar
Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses|January 11, 2021
The Effect of a Continuous Milk Warming System on Weight Gain in Very Low Birth-Weight Infants: A Randomized Controlled TrialSusan M Bedwell, Barbara Buster, Krishnamurthy Sekar
Frontiers in Pediatrics|April 19, 2021
The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?Frederico Vieira, Marjorie Makoni, Edgardo Szyld, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|November 3, 2012
A Cost Minimization Comparison of Two Surfactants-Beractant and Poractant alfa-Based Upon Prospectively Designed, Comparative Clinical Trial DataWallace Marsh, James Smeeding, John M York, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 26, 2019
Health Economics and Outcomes of Surfactant Treatments for Respiratory Distress Syndrome Among Preterm Infants in US Level III/IV Neonatal Intensive Care UnitsKrishnamurthy Sekar, Daniel Fuentes, Michelle R Krukas-Hampel, et al.
American Journal of Perinatology|April 16, 2004
A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infantsRangasamy Ramanathan, Maynard R Rasmussen, Dale R Gerstmann, et al.
Children (Basel, Switzerland)|June 2, 2021
Inhaled Nitric Oxide at Birth Reduces Pulmonary Vascular Resistance and Improves Oxygenation in Preterm LambsSatyan Lakshminrusimha, Sylvia F Gugino, Krishnamurthy Sekar, et al.
Pediatric Research|November 1, 2019
Inhaled nitric oxide as an adjunct to neonatal resuscitation in premature infants: a pilot, double blind, randomized controlled trialKrishnamurthy Sekar, Edgardo Szyld, Michael McCoy, et al.
The Journal of Pediatrics|June 20, 2020
Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical TrialRangasamy Ramanathan, Manoj Biniwale, Krishnamurthy Sekar, et al.
The Journal of Pediatrics|August 21, 2020
ReplyRangasamy Ramanathan, Manoj Biniwale, Krishnamurthy Sekar, et al.
Pageof 1